IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy

INTRODUCTION: DUAL II Japan (NCT02911948) was a 26-week, phase 3a randomized, treat-to-target trial which compared the efficacy and safety of IDegLira with degludec in 210 Japanese patients with type 2 diabetes (T2D) uncontrolled on premixed or basal insulin therapy. The DUAL II Japan trial presente...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Ther
Main Authors: Watada, Hirotaka, Ross Agner, Bue F., Doshi, Ankur, Bardtrum, Lars, Ranthe, Mattis Flyvholm, Billings, Liana K.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2019
Assuntos:
Brief Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965526/
https://ncbi.nlm.nih.gov/pubmed/31760599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00730-y
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares